Enterprise Value
2.566M
Cash
21.84M
Avg Qtr Burn
-4.015M
Short % of Float
0.50%
Insider Ownership
30.03%
Institutional Own.
7.09%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Oral CC-42344 Details Influenza | Phase 2a Data readout | |
CC-31244 (Pan-genotypic NS5B NNI) Details Hepatitis C | Phase 2a Update | |
CDI-988 Details COVID-19, Norovirus | Phase 1 Data readout | |
Inhaled CC-42344 Details Influenza | Phase 1 Initiation | |
CDI-45205 Details COVID-19 | IND Submission |